Ambee Pharmaceuticals PLC announcements
253 Dhaka Stock Exchange announcements for Ambee Pharmaceuticals PLC (AMBEEPHA) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2016 (15).
- Resumption after record date
Trading of the shares of the Company will resume on 15.12.2016 after record date.
- Suspension for Record Date
Trading of the shares of the Company will remain suspended on record date i.e., 14.12.2016.
- Spot market trading suspended
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 11.12.2016 to 12.12.2016. Trading of the shares of the Company will remain suspended on record date i.e., 14.12.2016.
- Q1
EPS was Tk. 0.55 for July-September, 2016 as against Tk. 1.38 for July-September, 2015; NOCFPS was Tk. 3.35 for July-September, 2016 as against Tk. 3.16 for July-September, 2015. NAV per share was Tk. 25.37 as of September 30, 2016 and Tk. 24.82 as of June 30, 2016.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on December 06, 2016 at 3:15 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2016.
- Dividend Declaration
The Board of Directors has recommended 26% cash dividend for the 18 months period from January 01, 2015 to June 30, 2016. Date of AGM: 29.12.2016, Time: 10:00 AM, Venue: 184/1 Tejgaon Industrial Area, Dhaka-1208. Record date: 14.12.2016.The Company reported EPS of Tk. 3.41 and NOCFPS of Tk. 12.06 for the 18 months period from January 01, 2015 to June 30, 2016. The Company has also reported EPS of Tk. 2.71 and NOCFPS of Tk. 11.59 for the 12 months period from January 01, 2015 to December 31, 2015 whereas Tk. 0.70, and Tk. 0.47 respectively for the 6 months period from January 01, 2016 to June 30, 2016. NAV per share of Tk. 24.82 as of June 30, 2016 and Tk. 24.12 as of December 31, 2015.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (23.11.2016) following its corporate declaration.
- Board Meeting
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 22, 2016 at 3:15 PM to consider, among others, audited financial statements of the Company for the 18 months period from January 01, 2015 to June 30, 2016.
- Response by the Company of DSE Letter
In response to a DSE letter dated August 28, 2016, the Company has sent the following message to the investors of the Capital Market: "We herewith inform you that in this price hike of shares, we do not have any undisclosed material decision/information that might have impact on unusual upward movement in price hike and trading of volume of shares of Ambee Pharmaceuticals Ltd."
- Query Response
In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike.
- Land Purchase
The Company has informed that the Board of Directors has decided to purchase 12 Bigha land at Gazipur with a total value of Tk. 4.26 crore.
- Change of Financial year
The Company has informed that the Board of Directors of the Company has decided, according to the Companies Act, 1994 and the BSEC Directive Dated April 27, 2016, to extend the Financial Year of the Company by an additional period of 6 months comprising to 18 months period ending on 30th June, 2016 instead of 31st December, 2015 in order to comply with the uniform income year from July to June as per provision of Section 9 of the Finance Act, 2015.
- Decision for Buying (additional information)
With reference to the Company's earlier news (disseminated by DSE on 03.04.2016), the Company has further informed that, according to negotiated Quotation price for purchase, the total price of 100 HERO Splendor Pro Motor Cycle will be Tk. 14,500,000.00 with a unit price of Tk. 145,000.00 each and the total price of 2 Iissuzu NKR55L-2016 Covered Van will be Tk. 4,600,000.00 with a unit price of Tk. 2,300,000.00 each.
- Decision for Buying
The Company has informed that the Board of Directors has decided to buy 100 HERO Splendor Pro Motor Cycle and 2 Iissuzu NKR55L-2016 Covered Van for the Company under Lease Finance from GSP Finance.
- Credit Rating Result
ARGUS Credit Rating Services Limited (ACRSL) has announced the rating of the Company as "A-" for long term and "ST-2" for short term with stable outlook in consideration of audited financials of the Company up to December 31, 2014, unaudited financials up to September 30, 2015 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.